On July 2, 2025, JP Morgan analyst John Stansel downgraded healthcare services company Centene (CNC, Financial). The rating adjustment moved from "Overweight" to "Neutral."
In addition to the downgrade, JP Morgan also lowered its price target on Centene (CNC, Financial) from $75.00 to $48.00. This adjustment represents a 36% decrease in the projected value of the stock.
The reassessment by JP Morgan highlights a change in the analyst's outlook on Centene's (CNC, Financial) financial trajectory and potential stock performance. The new target is set in USD currency.
Investors and market watchers will likely keep a close eye on Centene's (CNC, Financial) performance in the coming months following this significant rating and price target change by a major financial institution.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 17 analysts, the average target price for Centene Corp (CNC, Financial) is $74.32 with a high estimate of $91.50 and a low estimate of $61.00. The average target implies an upside of 31.20% from the current price of $56.65. More detailed estimate data can be found on the Centene Corp (CNC) Forecast page.
Based on the consensus recommendation from 21 brokerage firms, Centene Corp's (CNC, Financial) average brokerage recommendation is currently 2.4, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Centene Corp (CNC, Financial) in one year is $96.63, suggesting a upside of 70.57% from the current price of $56.65. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Centene Corp (CNC) Summary page.
